SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068250
Filing Date
2014-11-14
Accepted
2014-11-14 10:02:33
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v393218_10q.htm 10-Q 325833
2 EXHIBIT 31.1 v393218_ex31-1.htm EX-31.1 10141
3 EXHIBIT 31.2 v393218_ex31-2.htm EX-31.2 10050
4 EXHIBIT 32.1 v393218_ex32-1.htm EX-32.1 4099
5 EXHIBIT 32.2 v393218_ex32-2.htm EX-32.2 4030
6 GRAPHIC tpg12.jpg GRAPHIC 125806
  Complete submission text file 0001144204-14-068250.txt   3864300

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20140930.xml EX-101.INS 632246
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20140930.xsd EX-101.SCH 36389
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20140930_cal.xml EX-101.CAL 24204
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20140930_def.xml EX-101.DEF 170839
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20140930_lab.xml EX-101.LAB 224718
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20140930_pre.xml EX-101.PRE 199468
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 141221090
SIC: 2834 Pharmaceutical Preparations